Clinical Trials of interest to cytokine & interferon researchers Non-Eosinophilic Biological Effects of IL-5 ClinicalTrials.gov ID NCT06026202 Sponsor Imperial College London Information provided by Imperial College London (Responsible Party) Last Update Posted 2023-10-30 A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov ID NCT06287528 Sponsor Memorial Sloan [READ MORE]
With the 2024 ICIS Young Investigator Awards recently announced, Signals+ Editorial Board Member, Maialen Sebastian-delaCruz, took the opportunity to catch up with some of the YI Award Winners of past years and asked them to share their experiences and describe the impact this award had in their careers. For some [READ MORE]
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP (FoxP3ITP) ClinicalTrials.gov ID NCT05410249 Sponsor Sohag University Information provided by Noha Saber Shafik, Sohag University (Responsible Party) Last Update Posted 2023-04-12 Targeting IL-17A for Treatment-Resistant Depression ClinicalTrials.gov ID NCT04979910 Sponsor Icahn School of Medicine at Mount Sinai [READ MORE]
Currently, I am still undergoing training in Professor You-Me Kim’s laboratory at KAIST, where I am investigating to reveal the novel function of eosinophils and how they are regulated. Cytokines 2023 in Athens marked my second international conference experience. Initially, conversing with foreigners felt incredibly awkward and daunting, but the [READ MORE]
Each year, the International Cytokine & Interferon Society (ICIS) is thrilled to welcome approximately 200 new members, each bringing unique experiences and perspectives that enrich our community. Did you know that you can meet many of these new members in our regular Signals+ feature, New Member Mini-Bios? Reach out, welcome [READ MORE]
When attending Cytokines / KAI 2024, the Local Organizing Committee wants to make sure you experience the best of Seoul. Here are the final two entries in our “Top 10 Must Visit” places in Seoul. Thanks to the Cytokines 2024 LOC member Jae Hun Shin, PhD, Yonsei University, Korea for [READ MORE]
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients (IGNORANT) ClinicalTrials.gov ID NCT05843786 Sponsor Hospices Civils de Lyon Information provided by Hospices Civils de Lyon (Responsible Party) Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) ClinicalTrials.gov ID NCT05535764 Sponsor University [READ MORE]
ICIS is my favorite Society I am involved in, and I am very honored to have received the Amanda Proudfoot Tribute Award for Advances in Chemokine Biology during Cytokines 2023 Conference. This award provides valuable support for my job hunting and encourages me to continue working on cytokines in the [READ MORE]
Join us for Cytokines 2024 / KAI 2024 and be inspired by an exceptional lineup of confirmed speakers. Share your cytokine research with over 2,000 participants from around the world by submitting an abstract for oral or poster presentation by the Abstract Submission and Student Member Travel Award application deadline of May 20, 2024. [READ MORE]
Long time ICIS member, Alberto Mantovani, was recently elected into the National Academy of Sciences (NAS) in recognition of his distinguished achievements in original research. See the May 3 issue of the Signals+ Newsletter for more on that honor. This issue, we’re pleased to feature Prof. Emeritus Mantovani in the [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
